These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 39277181)

  • 1. Metabolic reprogramming by mutant GNAS creates an actionable dependency in intraductal papillary mucinous neoplasms of the pancreas.
    Makino Y; Rajapakshe KI; Chellakkan Selvanesan B; Okumura T; Date K; Dutta P; Abou-Elkacem L; Sagara A; Min J; Sans M; Yee N; Siemann MJ; Enriquez J; Smith P; Bhattacharya P; Kim M; Dede M; Hart T; Maitra A; Thege FI
    Gut; 2024 Dec; 74(1):75-88. PubMed ID: 39277181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Assessment of Intraductal Papillary Mucinous Neoplasm for Predicting Concomitant Pancreatic Ductal Adenocarcinoma.
    Oi H; Hozaka Y; Akahane T; Fukuda K; Idichi T; Tanoue K; Yamasaki Y; Kawasaki Y; Mataki Y; Kurahara H; Higashi M; Tanimoto A; Ohtsuka T
    Pancreas; 2024 Nov-Dec 01; 53(10):e790-e795. PubMed ID: 38743932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Ziaziaris WA; Lim CSH; Sioson L; Gill AJ; Samra JS; Sahni S; Mittal A
    Cancer Med; 2024 Dec; 13(23):e70499. PubMed ID: 39660530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YAP1 Overexpression Enhances the Aerobic Glycolysis Process via Suppression of EGLN2 in Pancreatic Ductal Adenocarcinoma.
    Hu P; Dou R; Qi Z; Liu G; Su Y
    J Gene Med; 2024 Dec; 26(12):e70006. PubMed ID: 39647834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56α to initiate pancreatic cancer development.
    Tinsley SL; Chianis ERD; Shelley RA; Mall GK; Dhiman A; Baral G; Kothandaraman H; Thoma MC; English IA; Daniel CJ; Acosta LCS; Solorio L; Atallah Lanman N; Pasca di Magliano M; Narla G; Dykhuizen EC; Sears RC; Allen-Petersen BL
    Oncogene; 2024 Dec; 43(50):3673-3687. PubMed ID: 39443726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GNAS
    Ideno N; Yamaguchi H; Ghosh B; Gupta S; Okumura T; Steffen DJ; Fisher CG; Wood LD; Singhi AD; Nakamura M; Gutkind JS; Maitra A
    Gastroenterology; 2018 Nov; 155(5):1593-1607.e12. PubMed ID: 30142336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.
    Taki K; Ohmuraya M; Tanji E; Komatsu H; Hashimoto D; Semba K; Araki K; Kawaguchi Y; Baba H; Furukawa T
    Oncogene; 2016 May; 35(18):2407-12. PubMed ID: 26257060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Mutant KRAS Alleles With Morphology and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.
    Chao T; Wang ZX; Bowne WB; Yudkoff CJ; Torjani A; Swaminathan V; Kavanagh TR; Roadarmel A; Sholevar CJ; Cannaday S; Krampitz G; Zhan T; Gorgov E; Nevler A; Lavu H; Yeo CJ; Peiper SC; Jiang W
    Arch Pathol Lab Med; 2024 Dec; 148(12):1299-1309. PubMed ID: 38452805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and Pancreatic Cancer Initiation Via LAMA5/ITGA4 Axis.
    Parte S; Kaur AB; Nimmakayala RK; Ogunleye AO; Chirravuri R; Vengoji R; Leon F; Nallasamy P; Rauth S; Alsafwani ZW; Lele S; Cox JL; Bhat I; Singh S; Batra SK; Ponnusamy MP
    Gastroenterology; 2024 May; 166(5):842-858.e5. PubMed ID: 38154529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FRA1 controls acinar cell plasticity during murine Kras
    Li AL; Sugiura K; Nishiwaki N; Suzuki K; Sadeghian D; Zhao J; Maitra A; Falvo D; Chandwani R; Pitarresi JR; Sims PA; Rustgi AK
    Dev Cell; 2024 Nov; 59(22):3025-3042.e7. PubMed ID: 39178842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance evaluation of a CRISPR Cas9-based selective exponential amplification assay for the detection of KRAS mutations in plasma of patients with advanced pancreatic cancer.
    Shen Y; Zhang X; Zhang L; Zhang Z; Lyu B; Lai Q; Li Q; Zhang Y; Ying J; Song J
    J Clin Pathol; 2024 Nov; 77(12):853-860. PubMed ID: 37679033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic Modulators.
    Malasala S; Azimian F; Chen YH; Twiss JL; Boykin C; Akhtar SN; Lu Q
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse Models for Pancreatic Ductal Adenocarcinoma are Affected by the cre-driver Used to Promote KRAS
    Mousavi F; Thompson J; Lau J; Renollet N; Martin MB; McGue J; Hassan O; Frankel T; Shooshtari P; Pin CL; Bednar F
    Cell Mol Gastroenterol Hepatol; 2024 Nov; ():101428. PubMed ID: 39547411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human airway macrophages are metabolically reprogrammed by IFN-γ resulting in glycolysis-dependent functional plasticity.
    Cox DJ; Connolly SA; Ó Maoldomhnaigh C; Brugman AAI; Sandby Thomas O; Duffin E; Gogan KM; Ó Gallchobhair O; Murphy DM; O'Rourke SA; O'Connell F; Nadarajan P; Phelan JJ; Gleeson LE; Basdeo SA; Keane J
    Elife; 2024 Dec; 13():. PubMed ID: 39620891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of 9-gene panel in assisting fine needle aspiration cytology to diagnose thyroid cancer].
    Zhang YQ; Zhao H; Zhao LL; Sun Y; Wang C; Zhang ZH; Qiu T; Yang X; Xiao T; Guo HQ
    Zhonghua Zhong Liu Za Zhi; 2024 Nov; 46(11):1049-1057. PubMed ID: 39622737
    [No Abstract]   [Full Text] [Related]  

  • 18. Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism.
    Wu X; Adame-Garcia SR; Koshizuka K; Vo PTT; Hoang TS; Sato K; Izumi H; Goto Y; Allevato MM; Wood KC; Lippman SM; Gutkind JS
    Cancer Prev Res (Phila); 2024 Dec; 17(12):571-583. PubMed ID: 39463147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism.
    Patra KC; Kato Y; Mizukami Y; Widholz S; Boukhali M; Revenco I; Grossman EA; Ji F; Sadreyev RI; Liss AS; Screaton RA; Sakamoto K; Ryan DP; Mino-Kenudson M; Castillo CF; Nomura DK; Haas W; Bardeesy N
    Nat Cell Biol; 2018 Jul; 20(7):811-822. PubMed ID: 29941929
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.